250 related articles for article (PubMed ID: 15082202)
21. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.
Solsona E; Iborra I; Ricós JV; Monrós JL; Casanova J; Dumont R
J Urol; 1999 Apr; 161(4):1120-3. PubMed ID: 10081851
[TBL] [Abstract][Full Text] [Related]
22. Intravesical RTNF therapy of superficial bladder cancer. A phase I study of recombinant tumor necrosis factor administered intravesically to patients with superficial bladder cancer.
Grampsas SA; Kahn K; Crawford ED
Online J Curr Clin Trials; 1994 Mar; Doc No 117():[4845 words; 36 paragraphs]. PubMed ID: 8136939
[TBL] [Abstract][Full Text] [Related]
23. [Intravesical chemotherapy with 4'-Epi-Adriamycin in patients with superficial bladder tumors].
Tsushima T; Matsumura Y; Ozaki Y; Yoshimoto J; Obama T; Akagi T; Nasu Y; Ohmori H
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2502-5. PubMed ID: 6594972
[TBL] [Abstract][Full Text] [Related]
24. [Intravesical chemoprophylaxis with beta-interferon in superficial carcinoma of the bladder].
Migliari R; el-Demiry MI; Muscas G; Dore A; Migliari M; Usai E
Arch Ital Urol Nefrol Androl; 1991 Mar; 63(1):135-40. PubMed ID: 1830405
[TBL] [Abstract][Full Text] [Related]
25. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
[TBL] [Abstract][Full Text] [Related]
26. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
Niijima T; Koyanagi T; Maru A; Sakashita S; Koiso K; Ishikawa H; Uchida K; Shimazaki J; Isaka S; Akaza H
Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
[TBL] [Abstract][Full Text] [Related]
27. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
[TBL] [Abstract][Full Text] [Related]
28. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
[TBL] [Abstract][Full Text] [Related]
29. Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder.
Cervenakov I; Szoldova K; Mardiak J; Chovan D; Mala M; Slavov D
Bratisl Lek Listy; 2000; 101(6):317-20. PubMed ID: 11039202
[TBL] [Abstract][Full Text] [Related]
30. [Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence].
Hashimoto H; Yachiku S; Watabe Y; Niibori D; Yamauchi K; Osanai H; Ohashi K; Wakabayashi A; Fujisawa M
Gan To Kagaku Ryoho; 1994 May; 21(6):833-8. PubMed ID: 8185341
[TBL] [Abstract][Full Text] [Related]
31. [The study on intravesical instillation of THP in the treatment of in-situ and superficial bladder cancers].
Aota Y; Okamoto N; Morikawa S; Yoshida K
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1015-8. PubMed ID: 1626937
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of recurrence of superficial tumors of the bladder with intravesical epirubicin].
Lancina Martín JA; García Pérez M; Arrabal Martín M; Vilches Cocovi E
Actas Urol Esp; 1990; 14(2):112-4. PubMed ID: 2378265
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin.
Shuin T; Kubota Y; Noguchi S; Hosaka M; Miura T; Kondo I; Fukushima S; Ishizuka E; Furuhata A; Moriyama M
Cancer Chemother Pharmacol; 1994; 35 Suppl():S52-6. PubMed ID: 7994787
[TBL] [Abstract][Full Text] [Related]
34. Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study.
Melekos MD; Dauaher H; Fokaefs E; Barbalias G
J Urol; 1992 Feb; 147(2):371-5. PubMed ID: 1732596
[TBL] [Abstract][Full Text] [Related]
35. A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group.
Okamura K; Kinukawa T; Tsumura Y; Otani T; Itoh H; Kobayashi H; Matsuura O; Kobayashi M; Fukatsu T; Ohshima S
Eur Urol; 1998; 33(3):285-8; discussion 289. PubMed ID: 9555553
[TBL] [Abstract][Full Text] [Related]
36. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
Flamm J; Grof F
Urologe A; 1985 Jan; 24(1):31-5. PubMed ID: 4039083
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer. The Nagoya University Urological Oncology Group.
Okamura K; Murase T; Obata K; Ohshima S; Ono Y; Sakata T; Hasegawa Y; Shimoji T; Miyake K
Cancer Chemother Pharmacol; 1994; 35 Suppl():S31-5. PubMed ID: 7994783
[TBL] [Abstract][Full Text] [Related]
38. Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III.
Rajala P; Liukkonen T; Raitanen M; Rintala E; Kaasinen E; Helle M; Lukkarinen O
J Urol; 1999 Apr; 161(4):1133-5; discussion 1135-6. PubMed ID: 10081854
[TBL] [Abstract][Full Text] [Related]
39. [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor].
Noguchi S; Kubota Y; Shuin T; Miura T; Moriyama M; Sakuramoto T; Oshima H
Hinyokika Kiyo; 1984 Sep; 30(9):1153-8. PubMed ID: 6596878
[TBL] [Abstract][Full Text] [Related]
40. [The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma].
Kanematsu A; Tsuji Y; Kanba H; Noguchi T; Kamoto T; Okabe T
Hinyokika Kiyo; 2001 Jan; 47(1):1-4. PubMed ID: 11235213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
